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Abstract
High-dose-rate brachytherapy is a tumor treatment method where a highly radioactive
source is brought in close proximity to the tumor. In this paper we develop a simulated
annealing (SA) algorithm to optimize the dwell times at preselected dwell positions to
maximize tumor coverage under dose-volume constraints on the organs at risk. Compared
to existing algorithms, our algorithm has advantages in terms of speed and objective value
and does not require an expensive general purpose solver. Its success mainly depends on
exploiting the efficiency of matrix multiplication and a careful selection of the neighboring
states. In this paper we outline its details and make an in-depth comparison with existing
methods using real patient data.
This is an author-created, un-copyedited version of an article published in Physics in Medicine and Biology
DOI:10.1088/0031-9155/61/3/1155.
1 Introduction
High-dose-rate (HDR) brachytherapy is a form of radiation therapy in which the tumor is
temporarily exposed to a highly radioactive source which dwells at different positions in or
around the planning target volume (PTV). For prostate tumors, the dwell positions are offered
by a temporary transperineal implant of catheters which run through the prostate. A remote
afterloader, which is connected to all the catheters, then sends a radioactive source through
the catheters one by one, stopping at several dwell positions inside the PTV. We assume that
the catheter locations and the dwell positions are known. The goal of the treatment planner is
to irradiate the PTV while sparing the surrounding organs at risk (OARs) by optimizing the
dwell time at each dwell position. Traditionally, treatment planning was a forward process,
where dwell times were adjusted until the dose distribution was satisfactory. In the last fifteen
years, inverse planning has been developed as a computerized technique where the dwell times
are optimized according to the treatment planner’s preferences on the dose distribution.
In the remainder of this introduction, we explain how dose distributions are evaluated, we
provide a literature review on the ongoing progress of inverse planning, and we show how this
work contributes to these developments.
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Figure 1: Dose-volume histogram for a prescribed dose of 8.5 Gy.
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Table 1: DVH protocol for a prescribed dose of 8.5 Gy for HDR prostate brachytherapy
based on Hoskin et al. (2007).
PTV Rectum Urethra
V100% ≥ 90% D10% ≤ 7.2Gy D10% ≤ 10Gy
Dmax ≤ 8Gy Dmax ≤ 10.6Gy
DVH criteria. The dose distribution within the PTV or an OAR is described in a dose-volume
histogram (DVH). Such a histogram displays the percentage of the structure receiving at least
a certain dose. An example histogram is displayed in Figure 1. Points on this histogram
are denoted by Dx or Vy, e.g., D10% is the minimum dose received in the hottest 10% of the
structure under consideration and V100% represents the percentage of the volume receiving 100%
of the prescribed dose. In a slight deviation from the above notation, Dmax is the maximal
dose received in the structure. These statistics are currently the most important quantitative
evaluation criteria (Hoskin et al., 2013). Besides these, the treatment planner inspects the
isodose lines in order to avoid undesired hot spots and cold spots.
Table 1 displays clinically used DVH criteria from a local hospital. In order to achieve tumor
control, V100% of the PTV needs to be at least 90%, i.e., at least 90% of the PTV’s volume need
to receive at least 100% of the prescribed dose. The limitation of complications is expressed
in DVH constraints on the rectum and urethra. D10% ≤ 7.2Gy for the rectum imposes that
90% of the rectum’s tissue may not receive more than 7.2Gy. A hard upper bound for tissue
in the rectum is set by Dmax ≤ 8Gy. For the urethra, 10Gy is the upper bound for 90% of the
tissue. The remaining 10% are allowed to reach radiation levels of at most 10.6Gy.
Dose measurement. In order to compute DVH statistics, the PTV and the OARs are discretized
into a grid of calculation points. The dose rates d˙ij describe the amount of radiation emitted
from dwell position j ∈ J towards calculation point i ∈ I per second. The dose at a calculation
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point i is equal to the sum of radiation received from each dwell position j:(
D˙t
)
i
=
∑
j∈J
d˙ijtj ,
where tj is the dwell time at dwell position j. Let D˙ be the |I| × |J | matrix with all dose rates
d˙ij. The matrix-vector product D˙t yields a vector that denotes the dose per calculation point.
Literature review. Traditionally, inverse planning for HDR brachytherapy is dose-based: the
treatment planner prescribes a lower bound Li and and an upper bound Ui on the desired
dose for each calculation point. Typically these bounds are the same for all calculation points
within the same structure. At each calculation point i, the received dose (D˙t)i is compared
to its respective prescribed lower and upper bounds. If the dose lies outside the interval
[Li, Ui], a penalty is imposed that is linear or quadratic in the deviation. A treatment plan is
optimal if it minimizes the sum of penalties over all calculation points. Linear penalty functions
have been successfully implemented in the commercially available algorithms Inverse Planning
by Simulated Annealing (IPSA) (Lessard and Pouliot, 2001) and Hybrid Inverse Treatment
Planning and Optimization (HIPO) (Karabis et al., 2005). Quadratic penalty functions are
used by Lahanas et al. (2003); Lahanas and Baltas (2003); Milickovic et al. (2002).
The disadvantage of dose-based penalty functions is that the resulting treatment plans may
need a posteriori adjustments as they do not necessarily adhere to the DVH criteria. More
recently, dose-volume based optimization methods have been developed that directly optimize
on DVH criteria. Panchal (2008) has formulated a Harmony Search heuristic. Siauw et al.
(2011) have presented a Mixed Integer Linear Programming (MILP) formulation and developed
the heuristic Inverse Planning by Integer Program (IPIP) to solve it. IPIP determines a
solution that is feasible and near-optimal for MILP by solving two Linear Programs (LPs).
Gorissen et al. (2013) have devised a formulation in which they directly optimize an MILP
using specific solver settings. Belie¨n et al. (2009) have introduced a hybrid approach based
on simulated annealing and linear programming. Their objective is dose-based, while the
delivered radiation to OARs is subject to dose-volume constraints. For the rectal constraint
D10% ≤ 7.2Gy, the linear constraint (D˙t)i ≤ 7.2Gy needs to hold for 90% of the calculation
points. The authors utilize simulated annealing to determine which calculation points are in
the group of 90%, and then use linear programming to determine the dwell times. According
to Belie¨n et al. (2009), the algorithm yields results superior to running the integer program
alone based on ten problem instances with 30 minutes computation time each. The authors
suggest the development of a pure SA algorithm without linear programming.
While our focus is on HDR brachytherapy, we briefly mention related research in Intensity
Modulated Radiotherapy (IMRT). Instead of irradiating the PTV by bringing a radioactive
source in close proximity to or inside the tumor, the patient is irradiated with radiation fields
at different angles around the patient. For fixed beam angles, the optimization problem for
determining the intensity map of each field is mathematically equivalent to the optimization
problem we study. Historically, these research fields have not been connected, perhaps due
to the different scale of the problems. For optimization in IMRT, we refer to Ehrgott et al.
(2010) and the extensive literature review by Zaghian et al. (2014). Simulated annealing is
also applied to IMRT treatment planning, e.g., Cho et al. (1998) optimize penalty functions to
meet dose criteria.
Our contribution. This paper follows up on Belie¨n et al. (2009)’s suggestion to develop a pure
simulated annealing (SA) heuristic to optimize on DVH statistics. We present DOPSA (DVH
Optimization by Pure Simulated Annealing), a novel algorithm that solves the same MILP
model as Gorissen et al. (2013) and Siauw et al. (2011). In this model the objective is to
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maximize V100% for the PTV, i.e., the volume of the PTV receiving at least the prescribed
dose, while meeting DVH constraints on the OARs. Our method exploits the speed of matrix
multiplication and uses a specialized generator for neighboring solutions. The heuristic has been
tuned by conducting many trial-and-error experiments. The parameters have been selected
using a metamodel, and have been validated with an out-of-sample analysis.
The advantage of SA over the existing dose-volume based models lies in its simple implementa-
tion independent of costly LP or MILP solvers. Since optimization is often offered as a separate
module for treatment planning systems, clinics may choose cheaper dose-based optimization
modules or keep using them if the price difference is too large, leaving the potential of dose-
volume based methods unused. Furthermore, the results in Section 3 show that our heuristic
has clear advantages over existing methods in terms of speed and objective value.
A short optimization time is of practical importance. In the clinical workflow (Balvert et al.,
2015), two treatment plans are made while the patient is anesthetized and continuously moni-
tored by an anesthesia care team. Moreover, the radiation oncologist is on standby while the
treatment planner makes the plan. Shortening the time needed to create a treatment plan
improves the clinical workflow and reduces the treatment costs.
The implementation details of DOPSA will be explained in the upcoming section, followed by
a discussion of the results and a comparison with existing algorithms in Section 3.
2 Methods
In this section we provide in-depth information about DOPSA. Its final implementation is the
result of a long trial-and-error process where many ideas have been tested. Here, we restrict
ourselves to a description of the final algorithm. For the selection procedure and parameter
tuning based on trial-and-error and a metamodel we refer the reader to Deist (2013). There,
values for the parameters (discussed below) have been determined by manual simulation and
a linear metamodel has been fitted to fine-tune each parameter. However, the explanatory
power of the model was low due to the presence of statistical noise. Note that only the data
of Patient 1 has been employed in the parameter tuning.
First, we describe the optimization model (Section 2.1) and the main steps in the algorithm
(Section 2.2). Then we focus on the two most important steps, which are the generation of
neighborhood states (Section 2.3) and checking feasibility (Section 2.4).
2.1 Optimization model
We use the same model as Gorissen et al. (2013) and Siauw et al. (2011) to allow a comparison
with their results. This model is based on the DVH protocol from Table 1 with exception
for the constraint on V100%. Instead of formulating a constraint V100% ≥ 90%, the model
is cast to maximize V100% under D10% and Dmax constraints on the OARs. Additionally, to
ensure that the dose distribution conforms to the PTV and to avoid high doses outside the
PTV in regions where there is no OAR to limit the dose in that region, we also consider an
artificial structure that surrounds the prostate at 2 mm distance. This collection of tissue is
henceforth denoted as the ‘shell’, and a constraint is added to ensure that the maximum dose
in this structure is below 8.5Gy. Furthermore, a dwell time modulation restriction (DTMR)
is added to avoid excessively high dwell times. The DTMR prohibits the dwell times of two
adjacent dwell positions within the same catheter to differ more than a factor two. A similar
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Table 2: Radiation bounds and τ for each structure.
PTV Rectum Urethra Shell
Li 8.5Gy 7.2Gy 10Gy 8.5Gy
Ui n/a 8Gy 10.6Gy 8.5Gy
τs n/a 0.9 0.9 1
restriction is found in other algorithms (Baltas et al., 2009). The complete optimization model
(Gorissen et al., 2013) is
max
1
|IPTV |
∑
i∈IPTV
vi (1a)
s.t.
(
D˙t
)
i
≥ Livi ∀i ∈ IPTV (1b)(
D˙t
)
i
≤ Li + (Ui − Li)(1− vi) ∀i ∈ IR ∪ IU ∪ IS (1c)∑
i∈Is
vi ≥ τs|Is| ∀s ∈ {R,U, S} (1d)
tj1 ≤ γtj2 ∀j1 ∈ J j2 ∈ Γ(j1) (1e)
vi ∈ {0, 1} ∀i ∈ I (1f)
tj ∈ [0,∞) ∀j ∈ J. (1g)
The binary variable vi indicates whether calculation point i meets a certain dose criterion:
for a calculation point in the PTV, i.e., i ∈ IPTV , the corresponding vi is equal to one if the
received dose at those points is at least the prescribed dose of Li = 8.5Gy. These values are
enforced by the objective (1a) and constraint (1b). For a calculation point in the OARs rectum
(R), urethra (U), and shell (S), i.e., i ∈ IR ∪ IU ∪ IS, constraint (1c) allows vi to be one if the
received dose is at most the soft upper bound Li. If the received dose is between Li and the
hard upper bound Ui, vi = 0. Constraint (1d) enforces the soft upper bound on the dose for at
least a fraction τs of the calculation points. The corresponding parameter values are displayed
in Table 2. Note that for the shell, Li and Ui coincide and τs = 1, since only a single dose
constraint is imposed for this structure. Constraint (1e) enforces the DTMR, i.e., dwell times
at neighboring dwell positions in the same catheter may not differ by more than a factor γ.
For our implementation, γ = 2. The set Γ(j) contains all adjacent dwell positions of j.
2.2 Algorithm
The algorithm described below searches for a vector t such that objective (1a) is maximal and
all constraints (1b)-(1g) are satisfied. DOPSA has been implemented in MATLAB according to
Algorithm 1, an adapted version of a standard simulated annealing process (Kirkpatrick et al.,
1983). In simulated annealing, the feasible region is searched by selecting a new solution tnew in
the neighborhood of the current solution tcur and deciding whether to accept this new choice. A
solution which is not decreasing the objective function is always accepted, whereas decreasing
solutions are also accepted with a probability that decreases in the loss of objective function
value and the duration of the search. This rule is also named the metropolis criterion. The
acceptance probability is defined as
P (accept tnew) = min
{
1, exp f(t
new)−f(tcur)
ck
}
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with objective function f and ck regulating the probability’s sensitivity to lower objective
function values. The parameter ck is adjusted at each iteration k according to the well-known
exponential cooling schedule
ck = c0α
⌊ km⌋,
where m ∈ (0,∞) is a fixed number of iterations after which the initial temperature c0 is
rescaled by α ∈ (0, 1).
DOPSA’s code is designed to generate and evaluate multiple states simultaneously. All time-
consuming procedures within the heuristic thus become matrix-operations which decreases the
required CPU time per state. Essentially it is faster to check the feasibility of g states in one
operation than to check the feasibility of the g states individually, since computing D˙T , where
T is a |J |×g matrix with the g states as columns, takes less than g times longer than computing
D˙t for a single state t. This not only eliminates a for-loop in Matlab code, which is known to
be relatively slow, but more importantly, uses the fact that an efficient implementation of a
matrix multiplication procedure takes less operations than O(g|I||J |) when g ≥ 2.
Algorithm 1 Simulated Annealing Code
set the initial state to t = 0
set the temperature to c0
while running time ≤ 180 seconds do
every 15000 iterations: return to current optimum
generate neighborhood states
discard infeasible states
choose tnew from neighborhood according to highest V100%
decide acceptance
lower the temperature by scaling with α
end while
DOPSA is initialized with the dwell times set to zero because it should start in the feasible
region and, a priori, any other feasible state can only be determined at relatively high computa-
tional effort. Then, one state is chosen from the set of feasible candidates in the neighborhood
and is evaluated by the metropolis criterion as described in Section 2. Subsequently, the
temperature is decreased in every iteration according to an exponential cooling schedule with
parameters α = 0.99, m = 1, and c0 = 1.5. The search continues in the chosen state, if ac-
cepted, or restarts in the current state. After each 15,000 iterations, the state with the highest
V100% is selected and the search is restarted in the neighborhood of this state. This step is
included to recover from an unsuccessful attempt to escape from a local optimum. Returning
to the state with the highest V100% focuses the search to areas with high objective function
values and avoids unnecessary search efforts in low-potential regions.
The running time of DOPSA is restricted to a fixed limit (e.g., 180 seconds) to allow a com-
parison with existing methods and to test whether DOPSA can provide satisfactory results
within a short time-span. In practice, an alternative stopping criterion can be used, such as
the relative improvement of the objective value over the last n iterations, or user intervention
based on the coverage attained by the algorithm and the running time.
The performance of the algorithm was revealed to be insensitive to changes in the parameter
values of α and c0, suggesting that hill-climbing methods might be similarly successful.
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2.3 Generating neighborhood states
DOPSA generates a neighborhood solution t by perturbing the dwell times of the current state
tcur:
t = tcur + ⌊r⌉ ,
where r is a vector of the same size as t. The vector r is chosen randomly according to
rj ∼ N(0, 0.05) i.i.d. for all j in Jc, the set of dwell positions that are changed, and rj = 0 for
all j in J\Jc. The operator ⌊⌉ rounds the elements of r to one decimal place, which is the input
precision of the Flexitron remote afterloader (Nucletron BV, Veenendaal, the Netherlands).
Negative dwell times are subsequently set to 0.
For the DTMR, the dwell times in each catheter are adjusted one by one to ensure the relative
difference with the previous dwell time is less than a factor 2. This adjustment may increase
the number of changed entries in the dwell time vector.
Number of changed entries. We observed that controlling the number of dwell time changes
applied to a new state is fundamental to the performance of DOPSA. A lower number of
changes is more likely to yield a feasible new state. However, lowering this number decreases
the potential maximal increase in V100% in the new state, which is most notable in early
iterations. Since it is unlikely that big improvements can still be realized when the algorithm
stalls, a negative correlation between the number of changed entries and the improvement
over the past 200 iterations is introduced. Consequently, when the improvements get smaller,
newly generated states get a larger probability of being feasible while the risk of missing out on
potential large gains is minimal. In the first 200 iterations, all entries are subject to changes
before the dynamic adjustment begins. The warmup period of 200 iterations only affects the
initial phase of DOPSA since the total number of iterations is approximately 50000.
Let Jc denote the index set of entries in t
cur that are varied to construct a new vector t. The
relation between the cardinality of Jc and the improvement in V100% is defined by
|Jc| =
⌈
V k
100%
−V
k−200,max
100%
V
k−200,max
100%
|J |
⌉
,
where V k100% is the V100% attained in the current state t
cur at iteration k. V k−200,max100% is the
overall highest V100% attained until iteration k − 200.
Note that the states chosen during the search can also exhibit V100% lower than in preceding
iterations due to the metropolis criterion, resulting in a negative |Jc|. For that reason and to
maintain a natural upper bound, |Jc| is restricted to the interval [⌈0.02|J |⌉, |J |]. The lower
bound is chosen to be at least 1 (since |J | > 50 for practically all cases) since improvements
in V100% might only be attained with increases in dwell times for one dwell position while
simultaneously decreasing the dwell time of another position. Taking 2% of all entries as the
lower bound ensures sufficient dwell time changes in generated states.
Empirical results indicate that a newly generated state has six times the probability of being
feasible by using Jc compared to perturbing all dwell times. The number of states that are
dropped due to infeasibility decreases from 95% to 70%.
Dwell position selection. Once |Jc|, the number of dwell positions for which the dwell times are
perturbed, is chosen, the next step is to select that many dwell positions. The intention is to
alter dwell times such that the objective value is improved. This target is pursued by changing
the dwell times of the dwell positions close to the calculation points in the PTV that do not
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yet receive the prescribed dose. Since the distance between dwell position j and calculation
point i has an inverse squared relation to the dose rate d˙ij , the probability that dwell position
j is chosen in a single draw is therefore set to
P (j ∈ Jc) =
∑
i∈IPTV :(D˙t)i<8.5
d˙ij
∑
j˜∈J
∑
i∈IPTV :(D˙t)i<8.5
d˙
ij˜
,
where IPTV is the set of calculation points in the PTV. The denominator normalizes the term
to attain a probability distribution. Using probabilities rather than simply picking the closest
dwell positions bears the advantage that the set of states that can be generated from the current
state does not become too small. Occasionally also dwell positions further away are selected
which diversifies the search.
This methods requires a random sample of dwell positions in each iteration of the search.
Randomly sampling dwell positions without replacement in MATLAB is a computationally
expensive procedure. Our experiments have shown that sampling |Jc| items with replacement
and removing duplicates yields better results, due to a larger number of iterations in the same
running time. In a direct comparison, the average PTV coverage after a running time of 3
minutes over 50 replications was 0.12% higher when using sampling without replacement.
Number of generated states. In the early stages of the search process, improving states can
be determined with few generated states per iteration since the improvement potential in the
neighborhood of tcur is high. Later on, an intensification of the search in those neighborhoods is
most important. Moreover, intensification becomes necessary only when the search approaches
the boundary, where one expects to find optimal solutions. Therefore, DOPSA generates more
states when the boundary is reached (as suggested by Hedar and Fukushima (2006)). Intensi-
fication can be controlled with an opposite relation between the number of states generated in
a single iteration g and V100%:
g =
⌈
40
(
1−
V k
100%
−V
k−200,max
100%
V
k−200,max
100%
)⌉
.
g is limited to the interval [1, 40] because trial runs indicated that excessive state generation
does not further improve the DOPSA’s performance. In the first 200 iterations, g = 1 is used.
2.4 Checking feasibility
The feasibility of each generated state needs to be verified, which is one of the computationally
most expensive procedures next to computing V100%. Testing each constraint discussed in
Section 1 requires a row subset of the matrix D˙ corresponding to a specific OAR to be multiplied
with the dwell time vector t. The computation time of checking a constraint increases with the
number of calculation points in the corresponding OAR.
The sequence in which the constraints on the DVHs for the OARs are checked is chosen to
minimize the required computation time: the most restrictive constraints with lowest computa-
tional cost are evaluated first. States that do not satisfy a constraint are immediately excluded
in order to reduce the computation time for checking other constraints.
The calculation of constraint values and V100% for newly generated states can be sped up by
using the values for the current state tcur that have been computed in the preceding iteration.
Let T cur denote the |J |×g matrix containing the current state as columns, and let T new denote
the |J | × g matrix with the neighboring states as columns.
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The dose computation for each generated state D˙T new can be reformulated as follows:
D˙T new = D˙T cur + D˙ (T new − T cur) .
The matrix product D˙T cur is known from the previous iteration, so only D˙(T new−T cur) needs
to be computed. T new − T cur is a sparse matrix with at most |Jc| non-zero entries per column
(plus additional non-zero entries due to the DTMR adjustment), since states generated in the
neighborhood of a current state only differ in approximately |Jc|-many entries. Moreover, the
sparsity increases over the search process. Using MATLAB’s toolpack for multiplication of
sparse matrices, an increase of the number of iterations over the total running time of 5% up
to 21% could be observed, depending on the number of dwell positions.
3 Results
The performance of DOPSA is assessed by a direct comparison with two existing dose-volume-
based methods: the MILP formulation by Gorissen et al. (2013) and the IPIP algorithm by
Siauw et al. (2011). The running time has been fixed to 3 minutes on an Intel Xeon E5620 2.4
GHz with 6 GB of memory. Both MILP and IPIP are solved using the state-of-the-art solver
CPLEX 12.4 (IBM).
3.1 Patient data
Tables 3 and 4 provide an overview of the three patient data sets. Each data set uses the same
number of calculation points in the PTV and the OARs. The PTV contains the biggest share
of calculation points since it is the largest organ. All dwell positions inside the PTV have been
activated based on a step size of 2.5 mm, resulting in 115 to 236 dwell positions per patient.
The number of inserted catheters is similar among patients with 17 for Patient 2 and 16 for
the other two patients. The dose rates have been calculated using the TG-43 formalism.
The calculation points have been generated with a Sobol sequence, which is a quasi-random
sampling technique that randomly distributes calculation points in such a way that the sam-
pling density is approximately uniform. This avoids the possibility that small subregions are
not covered with calculation points. Quasi-random sampling was shown to be excellent for
evaluating treatment plans (Niemierko and Goitein, 1990), although this effect may disappear
when the treatment plan is optimized with respect to the randomly sampled calculation points.
To avoid excessively high doses in points close to dwell positions, distances smaller than 0.83
mm are set to 0.83 mm (in the same direction).
Table 3: The number of calculation points per structure.
Structure Calculation Points
PTV 1750
Urethra 500
Rectum 250
Shell 250
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Table 4: The number of dwell positions and catheters for each patient.
Patient Dwell Positions Catheters
1 236 16
2 115 17
3 182 16
3.2 Running time and objective value
DOPSA has been tested on three patients. Since it is a random local search procedure, the
result can be subject to random effects. Therefore, the heuristic has been run 250 times for
each patient in order to provide a detailed analysis of the average treatment plan quality and
the variation in quality. If a low variation can be ensured for this optimization algorithm, only
a single optimization run per patient will be necessary in a clinical setting to obtain treatment
plans with consistent quality.
Figures 2-4 show the results for all three patient data sets. The average and standard deviation
in PTV coverage over 250 replications are displayed over the running time of 180 seconds. The
positioning of catheters determines the maximally achievable level of V100% in the PTV, which
explains the difference in objective values between patients. The high dependence on catheter
positioning is well observable for Patient 2 for whom only solutions with V100% < 50% can be
attained: inspecting the corresponding ultrasound scans reveals badly positioned catheters.
In all three cases, the PTV coverage increases rapidly within the first 30 seconds and further
improvements on the treatment plan quality are achieved over the remaining running time.
Every treatment plan determined by DOPSA is feasible, i.e., it always satisfies the DVH criteria
imposed on the OARs and dwell time constraints (see constraints (1c)-(1g)).
The absolute standard deviations in PTV coverage after a running time of 3 minutes for each
of the 250 replications are 0.09%, 0.33%, and 0.23%, respectively. Therefore, DOPSA delivers
treatment plans with consistent quality across replications.
3.3 Comparison with existing DVH-based optimizers
For the comparison with existing DVH-based optimizers, we have run an MILP solver with
the solver settings from Gorissen et al. (2013) and we have implemented IPIP (Siauw et al.,
2011). The original IPIP has been extended by the DTMR to ensure a fair comparison. These
two methods have been run on the same three patient data sets and on the same model. It
is important to recognize that IPIP can only provide a single solution per data set, whereas
MILP and DOPSA continue improving the solution. This is observable in Figures 5-7, where
the line for IPIP remains flat after a single increase. In theory, MILP could stop when it proves
that the solution is optimal, but this did not happen for any of the patients.
Figures 5 to 7 show the average PTV coverage obtained by DOPSA and the coverage obtained
by the existing methods MILP and IPIP. The running time for Patient 3 has been extended to
5 minutes since MILP requires more than 3 minutes to find non-zero feasible points.
IPIP attains adequate PTV coverage within less than 6 seconds for each patient. All those
solutions are initially superior to treatment plans found by DOPSA. Over the running time of
3 minutes, however, DOPSA consistently outperforms IPIP for all patient data sets. In each
of the 250 replications for all three patients, the PTV coverage after 3 minutes is higher for
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Figure 2: Average and standard deviation in PTV coverage for Patient 1 (250 replications).
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Figure 3: Average and standard deviation in PTV coverage for Patient 2 (250 replications).
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Figure 4: Average and standard deviation in PTV coverage for Patient 3 (250 replications).
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DOPSA than for IPIP. The average PTV coverage attained by DOPSA exceeds the results by
IPIP after only 18, 6, and 12 seconds, respectively.
MILP requires substantially more time to determine good treatment plans. For 2 out of 3
patients, MILP requires more than 1 minute to determine a treatment plan with non-zero
PTV coverage. However, after 3 minutes for Patients 1-2 and 5 minutes for Patient 3 it has
found the best plan among the three algorithms.
Unfortunately, the optimal objective values are not known. There is still a large gap between
the best solution found by any of the algorithms and the upper bound provided by the MILP
solver, and this gap does not decrease substantially after running the solver for a week. DOPSA
differs greatly from the existing dose-volume based methods while it finds similar objective
values. This could be an indication that much better solutions do not exist.
3.4 Model Discussion
The significance of the strong performance of DOPSA compared to the MILP by Gorissen et al.
(2013) becomes apparent when closely investigating the structure of the MILP (1a)-(1g). Be-
low, we show that the MILP is equivalent to the well-known ℓ0-norm minimization, and that
an MILP solver implicitly uses a method that is known to be effective in approximating the
ℓ0-norm. Therefore, we conclude that DOPSA displays a remarkable performance by outper-
forming MILP in terms of solution speed.
The objective (1a) is to maximize the number of calculation points that receive the prescribed
dose of 8.5 Gy. Let us first define the vector y, indexed by i in IPTV as follows:
yi = max
{
0,
8.5−(D˙t)
i
8.5
}
.
Since yi is zero if calculation point i receives at least the prescribed dose, minimizing the
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Figure 5: Comparison of PTV coverage for DVH-based optimizers for Patient 1.
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Figure 6: Comparison of PTV coverage for DVH-based optimizers for Patient 2.
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Figure 7: Comparison of PTV coverage for DVH-based optimizers for Patient 3.
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number of non-zero elements in y yields a treatment plan with maximal V100%. The number
of non-zero elements is ||y||0 (recall that the ℓ0-norm counts the number of non-zero elements
in a vector). D10% and Dmax can be rewritten similarly. Thus, the Lagrangean of the MILP
(1a)-(1g) is equivalent to an ℓ0-norm minimization. Attaining sparse vectors by minimizing
the ℓ0-norm has been shown to be NP-hard (Natarajan, 1995).
An MILP solver first solves the following LP relaxation:
max
x∈[0,1],t≥0
{ ∑
i∈IPTV
xi : (D˙t)i ≥ 8.5xi, (x, t) ∈ X
}
, (2)
where X is a polyhedron. Substituting yi = 1− xi yields the following equivalent program:
min
y∈[0,1],t≥0
{ ∑
i∈IPTV
|yi| : yi ≥
8.5−(D˙t)i
8.5
, (1− y, t) ∈ X
}
.
So, the LP relaxation (2) is equivalent to ℓ1-norm minimization. Literature, predominately in
the field of image processing, suggests that an optimal solution for the ℓ1-norm minimization
(linear relaxation of the MILP) provides a good approximation of an optimal solution for the
ℓ0-norm minimization (MILP): Donoho (2006) shows that, in most cases, the ℓ1-approximation
is also the sparsest solution for underdetermined systems of equations. Li (2010) discusses
necessary and sufficient conditions for the equivalence of ℓ0-norm and ℓ1-norm solutions in
general. These conditions do not hold in our case. Nevertheless, Candes et al. (2005) provide
numerical evidence for the power of these ℓ1-approximations. So, when the MILP (1a)-(1g) is
solved with an MILP solver, the solver implicitly uses an approximation that is known to be
accurate. This explains the results by Gorissen et al. (2013), where an MILP solver quickly
determines good treatment plans. However, our results in Section 3.3 show that DOPSA still
outperforms an MILP solver in finding good solutions in a short time-span, which advocates
the power of DOPSA.
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Compared to MILP-based formulations, DOPSA has another advantage. When more DVH-
constraints are added, the time for constraint verifications increases linearly, or sublinearly
when solutions are removed in the process. Contrarily, both the number of variables and the
number of constraints of the MILP formulation grow linearly in the number of DVH criteria,
which slows down an MILP solver at least quadratically. For example, when the LP relaxation is
solved with an interior point method, the time complexity of solving the KKT system increases
at least quadratically in the number of variables. A dual solver cannot alleviate this slowdown
since the number of constraints increases as well.
4 Conclusions
The existing dose-volume based optimization methods MILP and IPIP have not been compared
before. Our results show that each method has its own advantages. IPIP is faster while MILP
determines a better solution.
DOPSA, our new algorithm, is a viable alternative to both. Its main advantage is that it does
not require a costly solver. The time it takes to determine a good solution is less than MILP
but slightly more than IPIP. Since IPIP returns a single solution quickly but does not keep
improving the solution, DOPSA eventually determines better treatment plans. This leads to
two observations: first, advances in computing power will reduce the absolute time difference
between both methods, making IPIP lose its edge. Second, it is possible to combine the
strength of two methods and use the IPIP solution as a starting point for DOPSA. However,
the additional costs for an LP solver required by IPIP and the added complexity is not justified
by the slight improvement in solution time.
We have disclosed all information necessary to implement DOPSA. We hope it receives more
testing by the community, and will eventually become available to treatment planners.
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